Lumos Diagnostics
71 employees on LinkedIn · 1 known investors
Find your way into Lumos Diagnostics
360 people in our graph share verified history with the Lumos Diagnostics team — schools, employers, funds. One of them is your warm intro.
Rache Simmonsunlockedknows Doug Ward · together at Hologic (overlapped)
×6knows the team · via Bucknell University
×5knows the team · via Bayer HealthCare
Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.
Founders & leadership
DW
Doug WardinCEODoug Ward previously held leadership roles at Ventana Medical Systems, where he worked in the companion diagnostics sector, and at Personal Genome Diagnostics (PGDx), where he contributed to developing genomic in vitro diagnostic tests. He has held CEO and multi-functional management positions across R&D, regulatory affairs, and commercial operations at diagnostics and healthcare companies including GE Healthcare, Siemens Healthcare, and Roche Group.
Board
SL
Sam LanyonNon-Executive Chair
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountshare purchase planMay 2026Source ↗
- Undisclosed amountinstitutional placementMar 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Lumos Diagnostics sets up US growth push after landmark year for FebriDx | ASX:LDX, OTC:LDXHFproactiveinvestors.com · Aug 2026Frequently asked questions
- What does Lumos Diagnostics do?
- Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.
- Who are Lumos Diagnostics's investors?
- Lumos Diagnostics's investors include Tenmile.